Ministry Identifies Additional Cases: 8 Long-Term Care Hospitals, 4 Korean Medicine Hospitals

Suspected Practices Include Advance Payments for High Medical Fees Followed by Cash or Goods Refunds

The Ministry of Health and Welfare has requested the police to conduct additional investigations into 15 medical institutions suspected of so-called ‘payback’ practices—such as advance payment of high medical expenses and refunding of medical fees—targeting policyholders of indemnity medical insurance.


15 Hospitals and Clinics Suspected of 'Payback' Targeting Indemnity Insurance Referred for Investigation View original image

On August 28, the Irregular and Fake Medical Treatment Administrative Investigation Team announced that it had requested the National Police Agency to further investigate 15 hospitals and clinics suspected of abnormal or fraudulent medical treatment, including illegal refunds of medical expenses. This marks the third such request, following two previous ones in July. As a result, since the launch of the investigation team in June, the total number of medical institutions referred for investigation now stands at 33.


The medical institutions subject to this most recent request include 8 long-term care hospitals, 4 Korean medicine hospitals, 1 general hospital, and 2 clinics. By region, the breakdown includes 4 in Gyeonggi Province, 3 in Seoul, and 3 in Jeonnam/Gwangju, among others. The investigation team selected these sites based on cases reported to the Abnormal and Fake Medical Treatment Report Center as of the end of July, as well as certain institutions identified during the second round of administrative investigations where there was a need to verify specific violations.


Among these, many institutions were found to induce patients to make large advance payments for medical fees after confirming their indemnity insurance status, and then reimburse part of those fees in cash or goods—a method suspected to constitute payback.


For example, at Hospital A, it was reported that staff checked whether cancer patients held indemnity insurance during the admission consultation, encouraged prepayment of a treatment package worth about 10 million won, and offered to provide an indemnity insurance benefit of 500,000 won per month. There were also claims that if patients refused this arrangement, the hospital would reject the admission of other family members.


At Hospital B, regardless of patients’ actual health conditions, patients were reportedly encouraged to purchase high-priced inpatient packages, with admission refused if they declined. Other reported practices included providing part of the treatment fee in the form of café, nail salon, or massage vouchers, or supporting taxi fare to lure patients.


At Hospital C, it is suspected that so-called “discount management sheets” were maintained for individual patients, tracking their insurance status and managing discounts, outpatient care, and payments accordingly. Custom discounts were allegedly offered according to the exemption conditions of each insurance product. In particular, there were indications that medical records and prescriptions were written to differ from the actual treatment provided, enabling patients to receive insurance payouts—something deemed to require further investigation.


At Hospital D, it is suspected that cash payments were used for admission and discharge fees to hide payback practices. Treatment schedules for procedures such as high-frequency or skin-beauty injections were prearranged for individual patients, and paybacks were provided based on monthly treatment costs. There were also reports that hospitalized patients were given permission to freely leave or stay out overnight.


The administrative investigation team plans to promote cooperation to strengthen the medical community’s self-monitoring and self-regulation functions. After several working-level discussions with the Korean Medical Association, it intends to activate the expert evaluation system and strengthen the role of regional medical societies. It also plans to commence a third round of administrative investigations in early September.



Kwak Soonheon, head of the Irregular and Fake Medical Treatment Administrative Investigation Team, said, “Irregular and fake medical practices are entrenched issues that harm honest medical institutions and patients, and lead to financial leakage in national health insurance and indemnity insurance systems. We will carefully scrutinize suspected cases reported to the center and thoroughly verify any violations through administrative investigations and legal referrals.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing